2024-11-22 - Analysis Report
## Eli Lilly and Co (LLY) Stock Analysis Report

**1. Performance Comparison and Divergence:**

Eli Lilly and Co. (LLY) is a global pharmaceutical company developing and manufacturing medicines and biologics.  The cumulative return for LLY is 589.06%, significantly outperforming the S&P 500 (VOO) with a cumulative return of 126.85%.  The difference in cumulative returns is 462.21%, placing it at the 68.92% percentile of its historical performance relative to the S&P 500.  This indicates LLY has substantially outperformed the market benchmark over the observed period.

The provided alpha and beta analysis shows consistently positive alpha (outperformance relative to the market) and a beta generally around 0.7 (less volatile than the market) across multiple years, further supporting the strong relative performance.  The increasing market capitalization (Cap(B)) also indicates growth.

**2. Recent Price Movement:**

* **Closing Price:** $749.6
* **5-Day Moving Average:** $741.23
* **20-Day Moving Average:** $806.99
* **60-Day Moving Average:** $877.1

The stock price is currently below all three moving averages, suggesting a short-term downtrend.

**3. Technical Indicators and Expected Return:**

* **RSI (Relative Strength Index):** 35.37 – This indicates the stock is currently in oversold territory.
* **PPO (Percentage Price Oscillator):** -0.73 –  A negative value suggests bearish momentum.
* **20-Day Relative Divergence:** -19.66% – Shows a recent decline in relative performance.
* **Expected Return:** 169.6% –  This suggests a significant potential for outperformance against the S&P 500 over a long-term (2+ years) investment horizon.  However, this is a forecast and actual returns may vary considerably. The current price of $749.6, being below its moving averages, suggests a potential rebound rather than a sudden drop.  However, it's crucial to consider that the market is unpredictable.


**4. Recent Financial Performance:**

The provided EPS and revenue data shows significant volatility.  While there are periods of strong revenue and EPS growth, there are also instances of negative EPS (e.g., 2023-11-02 and 2024-10-30).  A thorough analysis requires understanding the reasons behind these fluctuations, such as specific product launches, market conditions, and R&D expenses.  The latest EPS of 1.08 (2024-10-30) needs to be compared against analyst expectations to gauge the market's reaction.  Missing this crucial context makes a complete assessment impossible.

**5. Financial Information Analysis:**

The provided financial data shows consistently high profit margins (around 80%) and significant revenue across quarters.  However, the Return on Equity (ROE) fluctuates, ranging from a loss (-0.51%) to a high of 21.88%. This volatility in ROE needs further investigation to understand the underlying drivers.  More detailed analysis, including balance sheet information and cash flow statements, is needed for a comprehensive assessment of the company's financial health.

**6. News and Recent Issues:**

* **Missing Information:**  The prompt requests an analysis of recent news (within the last two days), specifically earnings news from sources like Shacknews and FINBOLD, along with analyst opinions and market outlooks.  This information is crucial for evaluating current sentiment and potential risks.  Without this data, a complete analysis cannot be provided.

**7. Comprehensive Summary:**

LLY has exhibited exceptional performance compared to the S&P 500 over several years, reflected in its consistently high cumulative returns and positive alpha.  However, the recent price action indicates a short-term downtrend.  Technical indicators suggest oversold conditions, presenting a potential buying opportunity for long-term investors.   The company demonstrates strong profitability but exhibits volatility in both EPS and ROE, requiring a deeper dive into the underlying reasons for these fluctuations.  The missing recent news and analyst opinions significantly hinder a complete risk/reward assessment. The forecast of 169.6% expected return is intriguing, but lacks context and should be interpreted with caution.

**8. Recommendations:**

A complete investment decision requires access to the missing information regarding recent news, analyst opinions, and a more detailed breakdown of the financial statements.   Further investigation into the reasons behind the fluctuating EPS and ROE is essential.  Despite the current downtrend, the long-term outlook for LLY seems positive based on its historical performance, but confirmation through additional research is critical before making any investment decisions.  Consult with a qualified financial advisor before making any investment.
